Senlin Zhang, Qi Ji, Qingwei Wang, Shaoyan Hu. "Prophylactic rituximab administered on day -1 during conditioning significantly reduces early EBV reactivation in pediatric allogeneic HSCT: Real-world evidence from a propensity-matched cohort of 834 patients." Blood, 2025. doi:10.1182/blood-2025-5988